• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.93% Nasdaq Up0.67%

    BioCryst Pharmaceuticals, Inc. (BCRX)

    3.38 Up 0.03(0.90%) 10:23AM EDT - Nasdaq Real Time Price
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.6
    Mean Recommendation (last week):2.6

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:6.75
    Median Target:5.50
    High Target:15.00
    Low Target:2.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Feb 9, 2016NeedhamDowngradeBuyHold
    Feb 9, 2016JefferiesDowngradeBuyHold
    Feb 9, 2016JP MorganDowngradeOverweightNeutral
    Feb 8, 2016Piper JaffrayDowngradeOverweightNeutral
    Jan 6, 2016JefferiesUpgradeHoldBuy
    Nov 11, 2015BofA/MerrillDowngradeNeutralUnderperform
    Oct 9, 2015BofA/MerrillDowngradeBuyNeutral
    Sep 9, 2015JefferiesInitiated Hold
    Jun 30, 2015BofA/MerrillUpgradeNeutralBuy
    Apr 21, 2015FBR CapitalInitiated Outperform

    More Upgrades & Downgrades for BCRX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy1111

    Data provided by Thomson/First Call

    Currency in USD.